Platelet concentrates for bone regeneration: Current evidence and future challenges.

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Orthopedic Surgery

Background:

• Activated platelet concentrates (PCs) are autologous blood products with supraphysiological platelet levels.
• PCs are utilized in bone regeneration due to osteoinductive growth factors released from alpha granules.
• Existing literature presents conflicting results regarding the efficacy of PCs in bone healing.

Purpose of the Study:

• To investigate potential reasons for inconsistent outcomes in bone regeneration using platelet concentrates.
• To explore the role of platelet dense granule constituents in modulating bone healing.

Main Methods:

• Review of preclinical and clinical studies on platelet concentrate efficacy in bone regeneration.
• Analysis of factors influencing platelet concentrate preparation and activation.
• Examination of the known effects of dense granule components (serotonin, ATP, Ca2+) on bone metabolism.

Main Results:

• Heterogeneity in study methodologies complicates evidence-based conclusions on PC effectiveness.
• Platelet alpha granules release growth factors beneficial for bone healing.
• Platelet dense granules contain substances (serotonin, ATP, Ca2+) with potential inhibitory effects on bone metabolism.

Conclusions:

• The inconsistent outcomes of platelet concentrates in bone regeneration may be partly explained by the inhibitory effects of dense granule contents.
• Further research is needed to elucidate the specific mechanisms by which dense granule components influence bone healing.
• Optimizing platelet concentrate preparations to mitigate potential negative effects could improve bone regeneration outcomes.